These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Topoisomerase IIalpha expression in pituitary adenomas and carcinomas: relationship to tumor behavior. Vidal S; Kovacs K; Horvath E; Rotondo F; Kuroki T; Lloyd RV; Scheithauer BW Mod Pathol; 2002 Nov; 15(11):1205-12. PubMed ID: 12429800 [TBL] [Abstract][Full Text] [Related]
6. [Immunohistochemistry for pituitary hormones and Ki-67 in growth hormone producing pituitary adenomas]. Brito J; Sáez L; Lemp M; Liberman C; Michelsen H; Araya AV Rev Med Chil; 2008 Jul; 136(7):831-6. PubMed ID: 18949157 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of tumor angiogenic factors in human pituitary adenomas. Niveiro M; Aranda FI; Peiró G; Alenda C; Picó A Hum Pathol; 2005 Oct; 36(10):1090-5. PubMed ID: 16226108 [TBL] [Abstract][Full Text] [Related]
8. Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen. Chae YS; Flotte T; Hsu DW; Preffer F; Hedley-Whyte ET Gen Diagn Pathol; 1996 Oct; 142(2):89-95. PubMed ID: 8950573 [TBL] [Abstract][Full Text] [Related]
9. Expression of cell proliferation markers in pituitary adenomas--correlation and clinical relevance of MIB-1 and anti-topoisomerase-IIalpha. Wolfsberger S; Wunderer J; Zachenhofer I; Czech T; Böcher-Schwarz HG; Hainfellner J; Knosp E Acta Neurochir (Wien); 2004 Aug; 146(8):831-9. PubMed ID: 15254805 [TBL] [Abstract][Full Text] [Related]
10. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients. Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A; Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794 [TBL] [Abstract][Full Text] [Related]
11. Diagnosis of pituitary adenomas on touch preparations assisted by immunocytochemistry. Kontogeorgos G; Bassiouka I; Giannou P; Vamvassakis E; Rologis D; Orphanidis G Acta Cytol; 1995; 39(2):141-52. PubMed ID: 7887060 [TBL] [Abstract][Full Text] [Related]
12. [Pituitary adenomas: relationship between invasiveness and proliferative cell nuclear index]. Tella Junior OI; Herculano MA; Delcelo R Arq Neuropsiquiatr; 2000 Dec; 58(4):1055-63. PubMed ID: 11105073 [TBL] [Abstract][Full Text] [Related]
13. Proliferation activity in pituitary adenomas: measurement by monoclonal antibody Ki-67. Knosp E; Kitz K; Perneczky A Neurosurgery; 1989 Dec; 25(6):927-30. PubMed ID: 2601824 [TBL] [Abstract][Full Text] [Related]
14. Multiregional sampling reveals a homogenous distribution of Ki-67 proliferation rate in pituitary adenomas. Wolfsberger S; Kitz K; Wunderer J; Czech T; Boecher-Schwarz HG; Hainfellner JA; Knosp E Acta Neurochir (Wien); 2004 Dec; 146(12):1323-7; discussion 1327-8. PubMed ID: 15480830 [TBL] [Abstract][Full Text] [Related]
15. Determination of Ki-67 labeling index in pituitary adenomas using MIB-1 monoclonal antibody. Lath R; Chacko G; Chandy MJ Neurol India; 2001 Jun; 49(2):144-7. PubMed ID: 11447433 [TBL] [Abstract][Full Text] [Related]
16. Indices of apoptosis and proliferation as potential prognostic markers in non-functioning pituitary adenomas. Ibrahim AE; Pickering RM; Gawne-Cain ML; King S; Lees PD; Ellison DW Clin Neuropathol; 2004; 23(1):8-15. PubMed ID: 14986928 [TBL] [Abstract][Full Text] [Related]
17. A clinicopathological and immunohistochemical study of clinically non-functioning pituitary adenomas: a single institutional experience. Rishi A; Sharma MC; Sarkar C; Jain D; Singh M; Mahapatra AK; Mehta VS; Das TK Neurol India; 2010; 58(3):418-23. PubMed ID: 20644271 [TBL] [Abstract][Full Text] [Related]
18. Biologic markers of invasive pituitary adenomas involving the sphenoid sinus. Gandour-Edwards R; Kapadia SB; Janecka IP; Martinez AJ; Barnes L Mod Pathol; 1995 Feb; 8(2):160-4. PubMed ID: 7777477 [TBL] [Abstract][Full Text] [Related]
20. [Significance of p53 protein expression and proliferative potential with MIB-1 on tumor recurrence of pituitary adenomas]. Miyagami M; Nakamura S No To Shinkei; 1998 Jan; 50(1):27-32. PubMed ID: 9493195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]